Skip to main content
. 2021 Jul 14;21(14):4808. doi: 10.3390/s21144808

Figure 2.

Figure 2

Evolution of the number of papers considering the issue of validation for the use of commercial wearable devices in chronic disease monitoring, with a distinction between papers using machine learning (in red) or not (in blue). The percentages given in red represent the proportion of studies using machine learning.